Welcome to our dedicated page for Addus HomeCare SEC filings (Ticker: ADUS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Addus HomeCare Corporation filings document a home care provider with personal care, hospice and home health operations. Form 8-K reports furnish quarterly and annual results of operations, Regulation FD disclosures and exhibit press releases, while amended 8-K filings provide acquisition-related financial statements and pro forma information for the completed purchase of Gentiva's personal care business by Addus HealthCare, a wholly owned subsidiary.
Proxy and annual-meeting filings cover board elections, auditor ratification, executive compensation votes and related governance disclosures. The filing record also includes capital-structure, material-event and shareholder-vote disclosures for the company's common stock.
Addus HomeCare Corp executive W. Bradley Bickham, who serves as COO, reported his equity position in a Form 3. He disclosed direct ownership of 34,678 shares of Common Stock of Addus HomeCare Corp as of a holding entry dated August 7, 2026. The filing also references a Power of Attorney for W. Bradley Bickham dated August 14, 2026, authorizing certain filing-related actions.
Addus HomeCare Corporation reported that Heather Dixon, President and Chief Operating Officer, left the company on August 7, 2026. The board expressed appreciation for her leadership and contributions.
On the same date, the company appointed W. Bradley (Brad) Bickham, age 63, as Chief Operating Officer on an interim basis. Bickham previously served as President and COO from March 2021 through September 2025 and as Executive Vice President and COO from January 2017 through March 2021, and most recently was Advisor to the Chief Executive Officer.
On August 10, 2026, Addus and Bickham entered into an Employment Agreement under which he will serve as COO through July 31, 2027, unless ended earlier or extended by mutual written agreement. The agreement provides an annualized base salary of $622,000 and fixed bonuses, and includes confidentiality, non‑competition and non‑solicitation provisions. The company states there are no family relationships or related‑party transactions requiring disclosure beyond a previously filed retention and transition agreement. A press release announcing these changes and describing Addus’s home care operations was also issued.
Addus HomeCare Corporation delivered higher results for the three and six months ended June 30, 2026. Net service revenues were $377.4 million for the quarter, up 8.0% from $349.4 million, and $741.0 million for the first half, up 7.8% from $687.2 million. Quarterly net income increased to $27.6 million, a 25.2% rise, and first-half net income reached $52.7 million, up from $43.3 million, with diluted EPS of $1.49 for the quarter and $2.85 year-to-date.
Growth was driven mainly by the personal care segment, which generated $296.0 million in Q2 revenue, supported by organic volume and the HomeCourt, Gold Horses and Helping Hands acquisitions. Hospice revenue rose to $64.2 million on organic growth, while home health revenue edged down to $17.2 million on lower patient volumes. Managed care organizations represented 38.6% of Q2 net service revenues, and Illinois personal care remained a key contributor, with the Illinois Department on Aging accounting for 17.7% of net service revenues in the quarter.
Cash generation and deleveraging were notable. Net cash provided by operating activities for the first half was $92.4 million, compared with $41.5 million a year earlier. Cash increased to $99.6 million, and long-term debt declined to $61.6 million from $121.0 million, after repaying $60.0 million on the revolving credit facility, leaving $577.8 million available to borrow. The company received $6.3 million of ARPA-related state funding in the first half, using $5.6 million primarily for caregiver recruitment and retention, and reported $12.4 million of deferred ARPA funding within government stimulus advances. The discussion highlights recent reimbursement increases in Illinois and Texas, a 2.6% Medicare hospice rate update, a projected 1.3% reduction in Medicare home health payments for 2026, CMS’s new Medicaid access rule with an 80/20 compensation requirement by mid-2030, and a six‑month nationwide moratorium on new Medicare hospice and home health enrollments.
Addus HomeCare Corporation reported higher results for the quarter ended June 30, 2026. Net service revenues were $377.4 million, an 8.0% increase from $349.4 million a year earlier. Net income rose to $27.6 million from $22.1 million, with diluted EPS of $1.49 versus $1.20.
Adjusted EBITDA increased 11.9% to $49.2 million. Adjusted net income was $32.0 million, or $1.73 per diluted share. For the first six months of 2026, net service revenues were $741.0 million, up 7.8%, and net income was $52.7 million, with adjusted EBITDA of $93.7 million.
Personal care delivered 6.8% organic revenue growth and represented 78.4% of second‑quarter revenues, hospice showed 11.1% organic revenue growth and contributed 17.0%, while home health represented 4.6%. Cash totaled $99.6 million against $64.3 million of bank debt, and operating cash flow was $40.0 million in the quarter.
Addus HomeCare Corp executive Heather Brianne Dixon, President and Chief Operating Officer, reported an open-market sale of 288 shares of common stock at $93.77 per share. According to the disclosure, the sale was made under a previously established Rule 10b5-1 trading plan to cover tax obligations arising from the vesting of restricted stock awards. After this transaction, she continues to hold 44,371 shares of Addus HomeCare common stock directly.
Addus HomeCare Corp director Veronica Hill-Milbourne received a grant of restricted common shares as equity compensation. She acquired 1,449 shares at no stated purchase price, increasing her direct holdings to 6,516 shares. These restricted shares were granted as a non-employee director award and will vest in full on June 10, 2027, aligning part of her compensation with the company’s future performance.
Lopez Esteban reported acquisition or exercise transactions in this Form 4 filing.
Addus HomeCare Corp director Esteban Lopez reported receiving a grant of 1,449 shares of common stock as a compensation award. These are restricted shares for non-employee directors that will vest in full on June 10, 2027. After the award, Lopez directly holds 4,649 shares.
RUSH JEAN reported acquisition or exercise transactions in this Form 4 filing.
Addus HomeCare Corp director Jean Rush received an equity grant of company stock. The Form 4 reports an award of 1,449 shares of Common Stock at no cash cost, increasing her directly held stake to 10,670 shares after the transaction.
According to the footnote, these are restricted shares granted to non-employee directors that will vest in full on June 10, 2027, meaning they are subject to service-based conditions until that date.
Weaver Susan T reported acquisition or exercise transactions in this Form 4 filing.
Addus HomeCare Corp director Susan T. Weaver received a grant of 1,449 shares of restricted common stock as compensation. These restricted shares were granted to a non-employee director and will vest in full on June 10, 2027. Following this award, Weaver directly holds 13,744 shares of Addus HomeCare common stock.
Addus HomeCare Corp director Darin J. Gordon received 1,449 shares of common stock as a restricted stock grant. The award carries no cash exercise price and increases his direct holdings to 14,244 shares. The restricted shares were granted as compensation for non-employee director service and will vest in full on June 10, 2027.